Alvotech seeks US approval for biosimilars to Simponi and Eylea

Alvotech is once again seeking US regulatory approval for its biosimilar versions of Johnson & Johnson's Simponi and Regeneron's Eylea. This marks another attempt by the company to bring these treatments to the American market.